| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $6.81B | $6.70B | $7.17B |
| YoY Revenue Growth % | +1.6% | -6.5% | — |
| Gross Profit | $2.69B | $2.63B | — |
| Gross Margin % | 39.5% | 39.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $393.1M | $110.7M | $621.5M |
| Operating Margin % | 5.8% | 1.7% | 8.7% |
| Net Income (GAAP) | $294.4M | $61.2M | $810.4M |
| EBITDA (Normalized) | $515.9M | $233.1M | $879.7M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $678.8M | $590.9M | $546.9M |
| Capital Expenditures (CapEx) | $153.5M | $153.0M | $322.7M |
| Free Cash Flow (FCF) | $525.3M | $437.9M | $224.2M |
| FCF Margin % | 7.7% | 6.5% | 3.1% |
| Return on Invested Capital (ROIC %) | 10.8% | 7.0% | 9.4% |
| Cash & Short-Term Equivalents | $874.8M | $604.0M | — |
| Total Debt (Short + Long Term) | $1.79B | $0 | $2.01B |
| Total Stockholders' Equity | $1.97B | $1.85B | $4.13B |